Format

Send to

Choose Destination
J Eur Acad Dermatol Venereol. 2017 Dec;31(12):1951-1963. doi: 10.1111/jdv.14454. Epub 2017 Sep 11.

European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.

Author information

1
Division of Evidence-Based Medicine, Department of Dermatology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
2
Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands.
3
Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
4
Department of Dermatology, Paul Sabatier University, Toulouse, France.
5
Department of Dermatology, Aberdeen Royal Infirmary, Aberdeen, UK.
6
Service de Dermatologie, Hôpital Ambroise Paré Université Paris V, Boulogne, France.
7
St Johns Institute of Dermatology, Guys and St Thomas' Hospital Foundation Trust, London, UK.
8
Hospital Universitario de la Princesa, Madrid, Spain.
9
Radboud University medical center and Radboud University, Nijmegen, The Netherlands.
10
Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
11
Cambridge, UK.
12
Roma, Italy.
13
Department of Dermatology, Psoriasis-Center University Medical Center Schleswig Holstein, Kiel, Germany.
14
Waterloo, Canada.
15
Dermatologikum Hamburg, Hamburg, Germany.
16
Section of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
PMID:
28895202
DOI:
10.1111/jdv.14454

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center